Schwarz Pharma Ltd.
Recorded under 3 name spellings.
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 abandoned · 4 no status recorded
Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 12/643,665 | Method for Treating Diabetic Peripheral Neuropathic Pain | Dec 21, 2009 | Abandoned |
| 12/304,012 | Peptide Compounds for Treating Refractory Status Epilepticus | Jun 15, 2007 | Abandoned |
| 11/989,082 | Jul 20, 2006 | No status recorded | |
| 11/794,386 | Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists | Dec 27, 2005 | Abandoned |
| 11/145,965 | Jun 7, 2005 | No status recorded | |
| 11/089,441 | Method for Treating Pain in Diabetic Distal Sensory Polyneuropathy | Mar 25, 2005 | Abandoned |
| 11/060,997 | Use of rotigotine for treatment or prevention of dopaminergic neuron loss | Feb 17, 2005 | Abandoned |
| 10/587,792 | Jan 28, 2005 | No status recorded | |
| 10/936,134 | Sep 7, 2004 | No status recorded | |
| 10/532,836 | Highly pure bases of 3,3-dipheyl propylamine monoesters | Apr 3, 2004 | Abandoned |